Obrazovna ustanova i godina sticanja akademskih titula
Medicinski fakultet Univerziteta Prišina, 1991
Mjesto specijalizacije i godina
Intera medicina, Medicinski fakultet Univerziteta Prišina, 1996
Subspecijalizacija iz endokrinologije i diabetologija, Ministarstvo zdravlja FBiH, 2011
Posebne procedure/Subspecijalizacija (1-2 primarne i najistaknutije)
Bolesti štitne žlijezde
Reproduktivna endokrinologija
Bolesti paratiroidne žlijezde
Debljina
Poremećaji metabolizma
Dijabetes
Osteoporoza
Bolesti hipofize
Bolesti nadbubrega
Radno iskustvo
Ljekar na stažu, Odjeljenje za endokrinologiju, dijabetes i bolesti metabolizma - Interna klinika - Medicinski fakultet u Prištini, 1991-1992
Specijalizant interne medicine, Odjeljenje za endikrinologiju, dijabetes i metabolizam - Interna medicina KBC Priština, 1992-1996
Specijalista interne medicine, Odjeljenje za endokrinologiju, dijabetes i bolesti metabolizma - KBC Priština, 1996-1999
Viši asistent interne medicine, Medicinski fakultet Univerziteta u prištini, 1998-1999
Specijalista internista - endokrinolog, Odjeljenje za internu medicinu - Kantonalna bolnica Goražde, 1999-2002
Specijalista internista - Subspecijalista endokrinolog i dijabetolog, Klinika za endokrinologiju, dijabetes i bolesti metabolizma - KCU Sarajevo, 2002-2005
Šef Dijagnostičko-polikliničkog odjela sa Dnevnom bolnicom, Klinika za endokrinologiju, dijabetes i bolesti metabolizma - KCU Sarajevo, 2005-2016
Subspecijalista endokrinolog i dijabetolog, Klinika za nuklearnu medicinu i endokrinologiju - KCU Sarajevo, 2016-2017
Viši asistent interne medicine i endokrinologije, Medicinski fakultet Univerziteta u Sarajevu, 2004-2008
Docent interne medicine i endokrinologije, Medicinski fakultet Univerziteta u Sarajevu, 2008-2013
Vandredni profesor interne medicine i endokrinologije, Medicinski fakultet Univerziteta u Sarajeu, 2013-2019
Konsultant za endokrinologiju Poliklinika i Dnevna bolnica „dr. Al-Tawil“ Sarajevo, 2017-2021
Direktor UniMed Poliklinika Univerziteta SSST Sarajevo, 2022-2025
Konsultant za endokrinologiju, Poliklinika UniMed Univerzitet SSST Sarajevo, 2025
Stručne publikacije
Books
Author of chapter Polycystic Ovary Syndrome in: Merita Emini Sadiku and Florian Toti. Endocrinology, Diabetology and Metabolism diseases, University of Pristina, Medical Faculty, Pristina, 2023. 337-351. ISBN978-9951-00-338-4
Guidelines for treatment of diabetes mellitus- Revision. The Bosnia and Herzegovina Society of Endocrinology and Diabetology; Sarajevo, 2021. 68 str. ISBN 978-9926-8195-2-1
“Polycystic Ovary Syndrome”, Perfecta, Sarajevo, 2019. (peer-reviewed book)
Guidelines for treatment of diabetes mellitus. The Bosnia and Herzegovina Society of Endocrinology and Diabetology; Sarajevo, 2017.-122 str; ISBN 978-9926-8195-1-4
Guidelines for treatment of hypoglycaemia. The Bosnia and Herzegovina Society of Endocrinology and Diabetology; Sarajevo, 2017. -38 str. ISBN 978-9926-8195-0-7
Endocrinology and diabetology in: Amra Macić Džanković and colleagues. Adult Health Care. University of Sarajevo. Faculty of Health Studies, 2014. ISBN 978-9958-692-11-6
Acute Porphyria, Clinical guidelines. Institute for scientific research and development, UCC Sarajevo, 2012.
3 chapters in: Becir Heljic and colleagues. Diabetologia. Medical Faculty Sarajevo, 2011.
Reformed curriculum of 4th year Medical studies with syllabus subjects. Sarajevo: Medical Faculty, 2011.
Reformed curriculum of 4th year Medical studies with syllabus subjects. Sarajevo: Medical Faculty, 2010.
Faruk Alendar, Zelija Velija-Asimi. "Diabetes and skin changes". UCC Sarajevo, 2010.
Diabetic microvascular complications in: Belma Ascic-Buturovic and colleagues. Prediabetes and diabetes type 2, Sarajevo, 2009.
Immune aspects of endocrine disease, and Components of immune system in Karamehic J; Dizdarevic Z, and colleagues. Clinical Immunology. Sarajevo: Svjetlost; 2007.
Heljic B, Hrisafovic Z, Velija-Asimi Z, Burekovic A, Stevanovic D. Guide for Diabetes Mellitus. Sarajevo. 2006.
Zelija Velija-Asimi, Edina Stevic. Proper nutrition a healthy and long life. Sarajevo; 2009.
Original scientific papers
1. Alnuaimi S, Reljic T, Abdulla FS, Memon H, Al-Ali S, Smith T, Serdarevic F, Velija Asimi Z, Kumar A, Semiz S. PPAR agonists as add-on treatment with metformin in management of type 2 diabetes: a systematic review and meta-analysis. Sci Rep. 2024 Apr 16;14(1):8809. doi: 10.1038/s41598-024-59390-z. PMID: 38627464; PMCID: PMC11021491.
2. Memon H, Abdulla F, Reljic T, Alnuaimi S, Serdarevic F, Asimi ZV, Kumar A, Semiz S. Effects of combined treatment of probiotics and metformin in management of type 2 diabetes: A systematic review and meta-analysis. Diabetes Res Clin Pract. 2023 Aug;202:110806. doi: 10.1016/j.diabres.2023.110806. Epub 2023 Jun 25. PMID: 37369280.
3. Beslic VK, Burekovic A, Drace Z, Velija-Asimi Z, Dizdarevic-Bostandzic A. Association of Inherited Genotype and Severity of Clinical Presentation in Subjects with Verified Pas III Disorder. Mater Sociomed. 2022 Jun;34(2):92-94. doi: 10.5455/msm.2022.34.92-94. PMID: 36199843; PMCID: PMC9478524.
4. Tarik Catic, Snjezana Pejicic Popovic, Zelija Velija Asimi, Lucia Hlavinkova. Costs of Diabetes Mellitus and Its Complications in Bosnia and Herzegovina. Mater Sociomed. 2022 Jun; 34(2): 111-116
5. Amela Bostandzic, Vanja Beslic, Ismana Surkovic, Sefkija Balic, Tanja Dujic, Zelija Velija Asimi, Azra Burekovic. IDegLira Improves Metabolic Control in Patients with Type 2 Diabetes Previously Treated with Premix Insulin. January 2022, Medical Archives 76(2):96 Follow journal. DOI: 10.5455/medarh.2022.76.96-100
6. Azra Burekovic, Zelija Velija Asimi, Dzenana Halilovic et al. Diabetes – a. Consequence of COVID-19 Infection January 2022. Materia Socio Medica 34(1):4. DOI: 10.5455/msm.2022.33.4-7
7. Milenkovic T, Bozhinovska N, Macut D, Bjekic-Macut J, Rahelic D, Velija Asimi Z, Burekovic A. Mediterranean Diet and type 2 Diabetes Mellitus: A Perpetual Inspiration for the Scientific World. A Review. Nutrients 2021, 13(4), 1307; doi: 10.3390/nu13041307
8. Jelica Bjekić-Macut, Tamara Vukašin, Zelija Velija-Ašimi, Azra Bureković, Marija Zdravković, Zoran Andrić, Marija Branković, Slobodanka Crevar-Marinović, Tatjana Madić, Olivera Stanojlović, Danijela Vojnović Milutinović, Sarantis Livadas, George Mastorakos. Polycystic ovary syndrome: a contemporary clinical approach, Current Pharmaceutical Design, 2021-01-19 | journal-article. DOI: 10.2174/1381612827666210119104721
9. Dujic T, Bego T, Malenica M, Velija-Asimi Z, Ahlqvist E, Groop L, Pearson ER, Causevic A, Semiz S. Effects of TCF7L2 rs7903146 variant on metformin response in patients with type 2 diabetes. Bosn J Basic Med Sci. 2019 May 9. doi: 10.17305/bjbms.2019.4181. [Epub ahead of print] PMID: 31070566
10. Mahmutovic L, Bego T, Sterner M, Gremsperger G, Ahlqvist E, Velija Asimi Z, Prnjavorac B, Hamad N, Causevic A, Groop L, Semiz S. Association of IRS1 genetic variants with glucose control and insulin resistance in type 2 diabetic patients from Bosnia and Herzegovina. Drug Metab Pers Ther. 2019 Mar 19. pii: /j/dmdi.ahead-of-print/dmpt-2018-0031/dmpt-2018-0031.xml. doi: 10.1515/dmpt-2018-0031. [Epub ahead of print]
11. Tamer Bego, Adlija Causevic, Tanja Dujic, Maja Malenica, Zelija Velija-Asimi, Besim Prnjavorac, Janja Marc, Jana Nekvindová, Vladimír Palicka, Sabina Semiz. Association of FTO gene variant (rs8050136) with type 2 diabetes and markers of obesity, glycaemic control and inflammation. J Med Biochem 2019; 38(2), 153-163. DOI: 10.2478/jomb-2018-0023
12. Dizdarevic-Bostandzic A, Begovic E, Burekovic A, Velija-Asimi Z, Godinjak A, Karlovic V. Cardiovascular Risk Factors in Patients with Poorly Controlled Diabetes Mellitus. Med Arch. 2018 Feb;72(1):13-16. doi: 10.5455/medarh.2018.72.13-16.
13. Godinjak A, Velija-Asimi Z, Burekovic A, Dizdarević-Bostandzić A, Jusufović S, Iglica A, Gicić S, Kukuljac A. Subclinical hypothyroidism is associated with atherogenic lipid profile in postmenopausal women. Turk J Endocrinol Metab 2017;21:37-41.
14. Godinjak A, Velija-Ašimi Z, Bureković A, Kulić M, Gicić S, Serdarević F. Subclinical inflammation: The link between increased cardiovascular risk and subclinical hypothyroidism in postmenopausal women. CMBEBIH 2017, IFMBE Proceedings, Springer Nature Singapore. 2017; 62: 235-240. DOI: 10.1007/978-981-10-4166-2_35
15. S. Semiz, T. Dujic, Z. Velija-Asimi, and A. Causevic, Pharmacogenomics of membrane transporters and metformin response in Type 2 diabetic patients, European Journal of Human Genetics, 2016.
16. Godinjak A, Velija-Ašimi Z, Kulić M, Bureković A, Šurković I, Dizdarević-Bostandžić A, et al. Subclinical hypothyroidism is associated with metabolic syndrome in postmenopausal women. Diabetologia Croatica. 2016; 45(1): 3-10.
17. Zelija Velija-Asimi, Azra Burekovic, Tanja Dujic, Amela Dizdarevic-Bostandzic, Sabina Semiz. Incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndrome. Bosn J Basic Med Sci. 2016;16(4):298-306. DOI: http://dx.doi.org/10.17305/bjbms.2016.1428
18. Dujic T, Causevic A, Bego T, Malenica M, Velija-Asimi Z, Pearson ER, Semiz S. Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes. Diabet Med. 2016 Apr;33(4):511-4. doi: 10.1111/dme.13040.
19. Bećir Heljić, Zelija Velija-Ašimi, Azra Bureković, Vanja Karlović, Azra Avdagić, Murisa Ćemalović. The role of natural supplement of apple vinegar and syrup in the management of type 2 diabetes mellitus. Journal of Health Sciences. 2014;4(3):1-5.
20. Semiz S, Dujic T, Velija-Asimi Z, Prnjavorac B, Bego T, Ostanek B, Marc J, Causevic A. Effects of Melatonin Receptor 1B Gene Variation on Glucose Control in Population from Bosnia and Herzegovina. Exp Clin Endocrinol Diabetes. 2014 Jun;122(6):350-5. doi: 10.1055/s-0034-1371871.
21. Velija-Ašimi Z. Evaluation of the association of vitamin D deficiency with gonadotropins and sex hormone in obese and non-obese women with polycystic ovary syndrome. Med Glas (Zenica). 2014 Feb;11(1):170-6.
22. Zelija Velija-Asimi, Sebija Izetbegovic, Jasenko Karamehic, Jozo Coric, Mirsad Panjeta, Amra Macic-Dzankovic, Jasminka Djelilovic-Vranic, Amela Dizdarevic-Bostandzic. The Effects of Dipeptidyl Peptidase-4 Inhibitors in Treatment of Obese Patients with Type 2 Diabetes. Med Arh. 2013 Oct; 67(5): 365-367. DOI: 10.5455/medarh.2013.67.365-367
23. Velija-Ašimi Z. Evaluation of endocrine changes in women with the polycystic ovary syndrome during metformin treatment. Bosn J Basic Med Sci. 2013 Aug;13(3):180-5.
24. Dzemal Ibricevic, Zelija Velija Asimi. Frequency of Prediabetes in Women with Polycystic Ovary Syndrome. Med Arh. 2013; 67(4): 282-5.
25. Adisa Šaković-Račić, Emina Alimanović-Halilović, Zelija Velija-Ašimi. Correlation of „dry eye” syndrome and grade of diabetic retinopathy in patients with diabetes. MEDICAL JOURNAL 2013; 19(3); 206-211.
26. Nermina Babić, Nesina Avdagić, Miralem Musić, Jasminko Huskić, Amela Dervišević, Zelija Velija Ašimi, Alma Mujanović-Narančić, Emina Nakaš-Ićindić. The mean platelet volume is increased in patients with type 1 snd type 2 diabetes mellitus, but not in subjects with impaired glucose tolerance. MEDICAL JOURNAL 2013; 19(3); 224-229.
27. Amela Dizdarevic-Bostandic, Azra Burekovic, Zelija Velija-Asimi, Amina Godinjak. Inflammatory Markers in Patients with Hypothyroidism and Diabetes Mellitus Type 1. Med Arh. 2013; 67(3): 160-161
28. Jasminka Djelilovic-Vranic, Azra Alajbegovic, Velija Zelija-Asimi, Maida Niksic, Merita Tiric-Campara, Senka Salcic, Azra Celo. Predilection Role Diabetes Mellitus and Dyslipidemia in the Onset of Ischemic Stroke. Med Arh. 2013; 67(2): 120-123doi: 10.5455/medarh.2013.67.120-123.
29. Zelija Velija-Asimi. The efficacy of octreotide LAR in acromegalic patients as primary or secondary therapy. Therapeutic Advances in Endocrinology and Metabolism February 2012 3(1): 3-9, doi:10.1177/2042018811434728.
30. Amina Godinjak, Zulfo Godinjak, Azra Burekovic, Ismana Surkovic, Amela Dizdarevic-Bostandzic, Zelija Velija-Asimi. Insulin Resistance and Lipid Accumulation Product in Corelation to Body Mass Index in Women with Polycystic Ovary Syndrome. Med Arh. 2012; 66(6): 409-411.doi: 10.5455/medarh.2012.66.409-411.
31. Sabina Semiz, Tamer Bego, Tanja Dujic, Zelija Velija-Asimi, Becir Heljic, Maja Malenica, Janja Marc, Barbara Mlinar, Barbara Ostanek, Besim Prnjavorac, Adlija Causevic. Association of NAT2 polymorphisms with type 2 diabetes in a population from Bosnia and Herzegovina. Archives of medical research 2011;42(4):311-7.
32. Zelija Velija-Ašimi, Halima Resić. Correlation of microalbuminuria, glomerular iltration, serum creatinine and haemoglobin in diabetics type 2. MEDICINSKI ŽURNAL / MEDICAL JOURNAL 2011; 17(2); 126-129.
33. Amra Macić-Džanković, Fuad Džanković, Belma Pojskić, Zelija Velija-Ašimi. Evaluation of risk markers fluctuation during an initial therapy with rosiglitazon in patients suffering from metabolic syndrome. BOSN J BASIC MED SCI. 2009; 9(4): 323-328.
34. Amra Macic-Dzankovic, Fuad Dzankovic, B. Pojskic, Z. Asimi. Reduction of cardiovascular risk-score in metabolic syndrome during an initial therapy with rosiglitazone. HealthMED, 2009; 3(3): 314-321.
35. Bećir Heljić, Zelija Velija-Ašimi, Mehmed Kulić. The statins in prevention of coronary heart diseases in type 2 diabetics. BOSN J BASIC MED SCI. 2009; 9(1):71-76.
36. Zelija Velija-Ašimi, Belma Aščić-Buturović, Senad Pešto. The role of subclinical hypothyroidism in polycystic ovary syndrome. MEDICINSKI ŽURNAL / MEDICAL JOURNAL 2009; 15(1-2); 34-35.
37. Nermina Babic, Zelija Velija-Asimi, Jasminko Huskic, Amela Dizdarevic-Bostandzic, Alma Mujanovic-Narancic, Emina Nakas-Icindic. Valuation of anthropometric indices in diabetic patients. FOLIA MEDICA FACULTATIS MEDICINAE UNIVERSITATIS SARAEVIENSIS. Journal of Medical Faculty University of Sarajevo, Bosnia & Herzegovina. 2009; 44(1-suppl):11.
38. Amira Dedić, Bećir Heljić, Amira Redžić, Edina Vranić, Zelija Velija-Ašimi. Interdisciplinary aspects of diabetes mellitus and novel drug delivery systems. MEDICINSKI ŽURNAL / MEDICAL JOURNAL 2009; 15(1-2); 64-68.
39. Velija-Ašimi Z. C-reactive protein in Obese PCOS Women and the Effect of Metformin Therapy. BOSN J BASIC MED SCI. 2007; 7(1):90-93.
40. Velija-Ašimi Zelija, Bećir Heljić, Zoran Hrisafović. Rosiglitazone and metformin treatment in diabetics with metabolic syndrome. MEDICINSKI ŽURNAL / MEDICAL JOURNAL 2008; 14(1-2); 5-7.
41. Kocić R; Spirovski D; Ćirić V, Velija-Ašimi Z. Impact of Diet, Physical activity, Lipid Status and Glycoregulation in Estimation of Score (Systemic Coronary Risk Evaluation) for ten Years in Postmenopausal Women. BOSN J BASIC MED SCI. 2007; 7(3):197-204.
42. Velija-Ašimi Z. Body weight changes in female patients with prolactinoma treated with bromocriptin. MEDICINSKI GLASNIK. 2007; 4(2):71-73.
43. Heljić B; Velija-Ašimi Z; Bureković A; Buturović B; Cerić A; Horozić B; Šakambet D; Dizdarević-Bostandžić A; Šurković I; Hasanbegović S, Stevanović D. LEAP (Lantus Early Acces Programme). MED ARH. 2005; 59(5):283-285.
44. Velija-Ašimi Z, Karamehić J. The Effects of Treatment of Subclinical Hypothyroidism on Metabolic Control and Hyperinsulinemia. MED ARH. 2007; 61(1):20-21.
45. Velija-Ašimi Z, Heljić B. The Effects of Valsartan on Lipid Profile in Normotensive Type 2 Diabetes patients. MED ARH. 2005; 59(5):311-12.
Nagrade i priznanja
Fellow of the American College of Endocrinology (FACE) (2020 to present)
Appreciation to the president for the successful work of the Society of endocrinologists and diabetologists in Bosnia and Herzegovina in two mandates 2016-2020 and 2020-2024.
Croatian Society for Diabetes and Metabolic Disorders award for international collaboration, 2024, Zagreb, Croatia
Recognition for contribution and support to the 4th Congress of Endocrinology and Diabetology in Bosnia and Herzegovina with international participation and contribution to the development of the Bosnia and Herzegovina Society of Endocrinology and Diabetology, 25-28/4/2024, Sarajevo, B&H
Award for contribution, support and outstanding performance, Bosnia and Herzegovina Society of Endocrinology and Diabetology, 02/10/2021, Neum, B&H
Certificate of Appreciation by Scientific Association of Endocrinologists and Diabetologists of Rrepublic of Macedonia in Recognition of Dedication to the Development of the Macedonian Diabetology. March 03/29/2019. Republic of Macedonia.
Award for contribution, support and outstanding performance, Bosnia and Herzegovina Society of Endocrinology and Diabetology, 04/21/2018, Sarajevo
Gratitude for support and contribution; Society of endocrinology and diabetology of Republika Srpska, o3/31/2018. Banja Luka
Award for regional collaboration, Croatian Society for Diabetes and Metabolic Disorders, Croatian Medical Association, Srebreno, Dubrovnik, 12-15 May 2016.
Award for contribution and outstanding performance at First Diabetes Days with International Participation. Scientific Association of Endocrinologists and Diabetologists of Republic of Macedonia. 04/03/2016, Mavrovo, Republic of Macedonia.
Title of Primarius, Federal Ministry of Health, 04/07/2014.
Golden Charter "Doctor Humanist of the Year" 11/30/2013.
Gratitude for the selfless contribution and support during school generation 2012/2013. Association of Students of the Medical Faculty in Sarajevo
Članstva
The Medical Chamber of Canton Sarajevo (2002–present) F09-R1-1286
The American Association of Clinical Endocrinologists – AACE (2004–present)
The European Endocrine Society – ESE (2006–present)
The European Association for the Study of Diabetes – EASD (2018–present)
The Endocrinology and Diabetology Society in Bosnia and Herzegovina (2017–present)
